Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update

Rhea-AI Summary

Rigel Pharmaceuticals (Nasdaq: RIGL) has scheduled its first quarter 2025 financial results announcement and business update for Tuesday, May 6, 2025, after market close. The company will host a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).

Investors can join the call through two options:

• Phone: 877-407-3088 (domestic) or 201-389-0927 (international)
• Webcast: Available through the Investor Relations section at www.rigel.com

Rigel, founded in 1996 and based in South San Francisco, is a biotechnology company focused on developing therapies for hematologic disorders and cancer. The webcast will be archived and accessible for replay through the company website for 90 days following the call.

Positive

• Maintains regular investor communication through scheduled earnings call and webcast
• Provides multiple access methods for investors (phone and webcast)
• 90-day replay availability of the webcast shows transparency

Negative

• None.

News Market Reaction

+0.82%

1 alert

+0.82% News Effect

On the day this news was published, RIGL gained 0.82%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SOUTH SAN FRANCISCO, Calif., April 29, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its first quarter 2025 financial results after market close on Tuesday, May 6, 2025. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business.

Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com. The webcast will be archived and available for replay for 90 days after the call via the Rigel website.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit  www.rigel.com.

Contact for Investors & Media:  
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com

Media:
David Rosen
Argot Partners
Phone: 646.461.6387
Email: david.rosen@argotpartners.com     

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-announces-conference-call-and-webcast-to-report-first-quarter-2025-financial-results-and-business-update-302440298.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

When will Rigel (RIGL) report Q1 2025 earnings?

Rigel (RIGL) will report its Q1 2025 financial results after market close on Tuesday, May 6, 2025.

How can investors join Rigel's (RIGL) Q1 2025 earnings call?

Investors can join by dialing 877-407-3088 (domestic) or 201-389-0927 (international), or access the webcast through Rigel's Investor Relations website at www.rigel.com at 4:30 p.m. ET on May 6, 2025.

Where can I find the replay of Rigel's (RIGL) Q1 2025 earnings webcast?

The webcast replay will be available for 90 days after the call on Rigel's website at www.rigel.com in the Investor Relations section.

What is Rigel's (RIGL) main business focus?

Rigel is a biotechnology company focused on discovering, developing, and providing novel therapies for patients with hematologic disorders and cancer.

How long has Rigel (RIGL) been in business?

Rigel was founded in 1996 and is based in South San Francisco, California.